Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

DAIICHI SANKYO COMPANY, LIMITED

(4568)
  Rapport
SynthèseGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur DAIICHI SANKYO COMPANY, LIMITED
18/10Nikkei 225 Edges Down 0.2% on Profit-Taking, Energy Outlook
13/10DEFENCE THERAPEUTICS INC. : Bei einer In Vitro-Studie erhöhen eie Accumtm-Varianten von De..
13/10Bei einer in vitro-studie erhöhen die accum(tm)-varianten von defence therapeutics die ..
13/10PRESS RELEASE : Defence Therapeutics Inc.: DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO ..
12/10DAIICHI SANKYO : Corporate Governance Report
05/10DAIICHI SANKYO : Astrazeneca - Enhertu granted Breakthrough Therapy Designation in US for ..
04/10Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca Receive Gra..
04/10FDA gibt Astrazeneca-Krebsmittel Enhertu Status als Durchbruchtherapie
04/10ASTRAZENECA : Daiichi Sankyo's Enhertu Gets US FDA Breakthrough Therapy Tag for Breast Can..
04/10AstraZeneca Says FDA Granted Breakthrough-Therapy Designation for Cancer Treatment Enhe..
21/09Nikkei 225 Falls 2.2% on China Property Outlook
21/09Japanese shares fall on Evergrande jitters; bargain-hunting limits losses
20/09DAIICHI SANKYO : Enhertu reduced the risk of disease progression or death by 72% vs. trast..
20/09DAIICHI SANKYO : Enhertu demonstrated robust and durable tumour response of 54.9% in patie..
20/09ASTRAZENECA : Touts Positive Survival Data for Cancer Therapies Imfinzi, Enhertu
20/09DAIICHI SANKYO : Enhertu demonstrated clinically meaningful and durable response in patien..
20/09ASTRAZENECA : Daiichi Sankyo's Enhertu Reduces Breast Cancer Death In Late-Stage Study
20/09ASTRAZENECA : Daiichi Sankyo's Enhertu Shows 55% Tumor Response Rate in Lung Cancer Patien..
20/09ASTRAZENECA : Daiichi Sankyo's Enhertu Prolongs Survival in Mid-Stage Gastric Cancer Study
18/09DAIICHI SANKYO : ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus T..
18/09Daiichi Sankyo Company, Limited and AstraZeneca Announce Reduction of Risk of Disease P..
18/09Daiichi Sankyo Company Demonstrated Robust and Durable Tumor Response of 54.9% in Patie..
18/09Daiichi Sankyo Company, Limited and AstraZeneca announce ENHERTU® Demonstrated Clinical..
17/09AstraZeneca Sees Positive Results for Enhertu Trial
17/09Daiichi Sankyo Company, Limited and Sarah Cannon Research Institute, LLC Announce DS-73..
17/09Japanese shares edge up as FOMO keeps rally alive
16/09DPA-AFX ÜBERBLICK : KONJUNKTUR vom 16.09.2021 - 17.00 Uhr
16/09IAEA hebt erstmals seit Fukushima Prognose für Atomenergie an
16/09Daiichi Sankyo Company, Limited and AstraZeneca Announces That the First Patient Was Do..
16/09China's biotech sector comes of age with big licensing deals, global ambitions
13/09DEFENCE THERAPEUTICS INC. : Health Europa berichtet über Defence Therapeutics: Die Accum-T..
07/09URAVAN MINERALS : Rises 20% as it Looks at Strategic Alternatives Because of Low Uranium P..
30/08Daiichi Sankyo Company, Limited Announces Results from the Multinational, Randomized, C..
20/08NIKKEI 225 : Declines 1% On Toyota, Pandemic Outlooks
20/08Nikkei falls to 8-month low as Toyota drags peers, materials makers
20/08Nikkei slides to 7-month low as Toyota drags peers, other cyclicals
19/08Defence therapeutics selects the best 8 accumtm variants to optimize its adc therapeuti..
19/08Toyota drags Nikkei to 7-month low after output cut report
19/08Japanese shares fall, struggle to shake off Delta variant fears
18/08IRW-PRESS : Defence Therapeutics Inc.: Defence Therapeutics wählt die besten 8 Accum(TM)-V..
18/08PRESS RELEASE : Defence therapeutics selects the best 8 accum(tm) variants to optimize its..
17/08NIKKEI 225 : Down 0.4% as Pandemic Undercuts Optimism
12/08Interim Results for the Six Months Ended 30 June -2-
10/08LOGICBIO THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Highlights Recen..
10/08DAIICHI SANKYO : Enhertu significantly improved progression-free survival in DESTINY-Breas..
09/08ENHERTU® (Fam-Trastuzumab Deruxtecan-Nxki) Significantly Improved Progression-Free Surv..
09/08ASTRAZENECA : Forxiga Nabs New EU Nod As Enhertu Logs Breast Cancer Win
09/08ASTRAZENECA : Breast Cancer Drug Shown to Extend Lives Better Than Roche's Kadcyla in Phas..
09/08DAIICHI SANKYO : ENHERTU® Significantly Improved Progression-Free Survival in DESTINY-Brea..
30/07MÄRKTE ASIEN/Schwach - Corona-Sorgen in Tokio nehmen zu
30/07MÄRKTE ASIEN/Schwächer - Fanuc und Fujitsu nach Zahlen sehr schwach
30/07DAIICHI SANKYO : Top Management Presentation
30/07DAIICHI SANKYO : Consolidated Financial Results for the First Three Months of the Year End..
30/07DAIICHI SANKYO : Reference Data
30/07Daiichi Sankyo Company, Limited Provides Dividend Guidance for the Year Ending March 31..
30/07Daiichi Sankyo Company, Limited Forecasts Dividend for the Second Quarter of Fiscal Yea..
30/07Daiichi Sankyo Company, Limited Provides Earnings Guidance for the Full Year Ending Mar..
30/07Daiichi Sankyo Company, Limited Reports Consolidated Earnings Results for the First Qua..
21/07Daiichi Sankyo Completes Issue of Shares in Stock Compensation Program
08/07ASTRAZENECA : Daiichi Sankyo, AstraZeneca's Late-Stage Trial of Enhertu for Gastric Cancer..
08/07ASTRAZENECA : Daiichi Sankyo Late-Stage Trial of Enhertu for Gastric Cancer Doses First Pa..
08/07Daiichi Sankyo Company, Limited and AstraZeneca Announces DESTINY-Gastric04 Head-to-Hea..
02/07Nikkei ends higher on Sony, Toyota boost; posts weekly drop on virus woes
01/07TOKYO ELECTRIC POWER INCORPORATED : Olympics-Japan PM says no spectators possible as Samoa..
23/06Chiude piatta, guadagni nei chip bilanciano perdite case farmaceutiche
23/06Daiichi Sankyo to Issue Common Stocks to Employees Under Share Compensation Plan
22/06DAIICHI SANKYO : Corporate Governance Report
15/06Japan's Daiichi Sankyo halts trials of existing drug for COVID-19 treatment
14/06BOURSE DE TOKYO : Borsa Tokyo in rialzo, Toshiba avanza dopo estromissione dirigenti board
14/06Japanese shares inch higher, Toshiba up after ouster of board directors
14/06Japanese shares track Wall Street higher, gains capped as investors await Fed's stateme..
11/06Daiichi Sankyo Company, Limited Announces New Data for valemetostat
11/06Daiichi Sankyo Announces That Delytact® Oncolytic Virus G47 Approves in Japan for Treat..
08/06Nikkei 225 Slips 0.2% on Inflation Outlook, Asian Market Softness
08/06Heavyweights pull Nikkei lower, Topix gains on drugmakers' boost
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur DAIICHI SANKYO COMPANY, LIMITED